Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Q301--DONOR-DERIVED CELL FREE DNA TESTING

U.S. Department Of Veterans Affairs·New York

Q301--DONOR-DERIVED CELL FREE DNA TESTING

Closes 11/14/2025$100k – $500kRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs is seeking information from contractors for donor-derived cell-free DNA (dd-cfDNA) testing services in support of the renal transplant program at the James J. Peters VA Medical Center. The contractor will provide accurate, timely, and secure dd-cfDNA testing to monitor kidney transplant recipients for potential allograft injury or rejection. The contractor must provide all necessary personnel, materials, equipment, transportation, and supervision to perform the services. * The contractor must have experience in performing tasks of this nature, scope, and complexity. * The contractor must provide a capability statement, examples of same or similar work performed at other facilities, and relevant documentation. * The contractor must comply with the limitations on subcontracting requirement specified in the contract. * The contractor must cooperate fully and make available any documents or records as may be required to enable the VA to determine compliance with the limitations on subcontracting requirement.

Attached files

Contact

Mariangie Rivera(Contracting Officer)

[email protected]

(518) 626-6246

Key dates

Opened
11/7/2025
Closes
11/14/2025

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
36C24226Q0126

Budget estimate

$100,000 – $500,000

The budget for this opportunity is difficult to estimate, as the document does not provide a specific dollar amount. However, based on the services being sought, it is likely that the budget will be in the range of $100,000 to $500,000 per year, depending on the frequency and volume of testing required. The contractor will need to provide all necessary personnel, materials, equipment, transportation, and supervision to perform the services, which will impact the overall cost. Additionally, the contractor must comply with the limitations on subcontracting requirement, which may also impact the budget. Factors that may influence the likely payment range include the number of kidney transplant recipients being monitored, the frequency of testing, and the complexity of the services being provided.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·Illinois

Top match · 76%

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

U.S. Department Of Veterans Affairs·New Jersey

70% match

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

LA County Sheriff·California

70% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

Iowa State University·Iowa

68% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. Department Of Health And Human Services·Maryland

68% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

Georgia Fulton County Purchasing Department·Georgia

68% match

26ITB1702547C-JH DNA Services

Closes 11/10/2026Opened 10/13/2026

U.S. Bureau of Justice Assistance·United States of America

67% match

BJA FY 2026 Postconviction Testing of DNA Evidence

Closes 12/8/2026Opened 10/28/2026

U.S. Bureau of Justice Assistance·United States of America

67% match

BJA FY26 DNA Capacity Enhancement for Backlog Reduction (CEBR)?Competitive Grants Program

Closes 11/3/2026Opened 9/23/2026

U.S. Department Of Health And Human Services·Maryland

67% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

67% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Defense·Maryland

67% match

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

66% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

66% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. National Institutes of Health·United States of America

66% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Department Of Veterans Affairs·Texas

66% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

66% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

Tarrant County·Texas

66% match

Purchase of Genetic Analysis Instrument and Maintenance

Closes 11/5/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

65% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

State of Alabama Office of the Chief Procurement Officer·Alabama

65% match

BCL27*382830-SoleSource-Geenius Reader, System-STD Testing

Closes 11/3/2026Opened 10/29/2026

Massachusetts Department of Public Health·Massachusetts

65% match

RFR 233132 Specialized Laboratory Testing Services

Closes 6/29/2032Opened 3/22/2022

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026